Avalo Therapeutics Inc
NASDAQ:AVTX
Avalo Therapeutics Inc
NASDAQ:AVTX
Price:
14.76
USD
7.97%
Market Closed
Market Cap:
$775.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Avalo Therapeutics Inc
NASDAQ:AVTX
|
US |
|
A
|
Atlantia SpA
XHAM:AU9
|
IT |
|
G
|
Grenergy Renovables SA
MAD:GRE
|
ES |
|
STERIS plc
NYSE:STE
|
IE |
|
C
|
CRH PLC
NYSE:CRH
|
IE |
|
F
|
Forestar Group Inc
F:4F31
|
US |
|
V
|
Vale SA
SWB:CVLB
|
BR |
|
E
|
Entergy Corp
DUS:ETY
|
US |
|
E
|
Emira Property Fund
JSE:EMI
|
ZA |
|
VICI Properties Inc
NYSE:VICI
|
US |
|
Aviva PLC
F:GU81
|
UK |
Multiples-Based Value
The Multiples-Based Value for Avalo Therapeutics Inc (AVTX) under the Base Case is hidden
USD.
Compared with the current market price of 14.76 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AVTX Multiples-Based Value
LOCKED
